Contents

CNS & Neurological Disorders - Drug Targets , Volume 9 - Number 1

Commentary [Research Highlights]

, 9(1): 1

Stephen D. Skaper


DOI: 10.2174/187152710790966669




Editorial [Hot topic: Pharmacotherapies for Alcoholism: The Old and the New (Guest Editor: M. Foster Olive)]

, 9(1): 2 - 4

M. Foster Olive


DOI: 10.2174/187152710790966722




Disulfiram: An Old Therapeutic with New Applications

, 9(1): 5 - 12

Kelly S. Barth and Robert J. Malcolm


DOI: 10.2174/187152710790966678




Naltrexone for the Treatment of Alcoholism: Clinical Findings, Mechanisms of Action, and Pharmacogenetics

, 9(1): 13 - 22

Lara A. Ray, Pauline F. Chin and Karen Miotto


DOI: 10.2174/187152710790966704




Acamprosate: A Prototypic Neuromodulator in the Treatment of Alcohol Dependence

, 9(1): 23 - 32

Barbara J. Mason and Charles J. Heyser


DOI: 10.2174/187152710790966641




Effectiveness and Safety of Baclofen in the Treatment of Alcohol Dependent Patients

, 9(1): 33 - 44

Lorenzo Leggio, James C. Garbutt and Giovanni Addolorato


DOI: 10.2174/187152710790966614




The Role of Topiramate and Other Anticonvulsants in the Treatment of Alcohol Dependence: A Clinical Review

, 9(1): 45 - 49

Avinash De Sousa


DOI: 10.2174/187152710790966696




Aripiprazole: A Drug with a Novel Mechanism of Action and Possible Efficacy for Alcohol Dependence

, 9(1): 50 - 54

Derick E. Vergne and Raymond F. Anton


DOI: 10.2174/187152710790966731




Blockade of the Cannabinoid CB1 Receptor and Alcohol Dependence: Preclinical Evidence and Preliminary Clinical Data

, 9(1): 55 - 59

Paola Maccioni, Giancarlo Colombo and Mauro A.M. Carai


DOI: 10.2174/187152710790966623




Neuronal Nicotinic Acetylcholine Receptors as Pharmacotherapeutic Targets for the Treatment of Alcohol Use Disorders

, 9(1): 60 - 76

S. Chatterjee and S. E. Bartlett


DOI: 10.2174/187152710790966597




Pre-Clinical Evidence that Corticotropin-Releasing Factor (CRF) Receptor Antagonists are Promising Targets for Pharmacological Treatment of Alcoholism

, 9(1): 77 - 86

Emily G. Lowery and Todd E. Thiele


DOI: 10.2174/187152710790966605




The Nociceptin/Orphanin FQ System as a Target for Treating Alcoholism

, 9(1): 87 - 93

Niall P. Murphy


DOI: 10.2174/187152710790966713




TRPC Channels and their Implications for Neurological Diseases

, 9(1): 94 - 104

Senthil Selvaraj, Yuyang Sun and Brij B. Singh


DOI: 10.2174/187152710790966650




Mitochondrial Metabolism Modulation: A New Therapeutic Approach for Parkinsons Disease

, 9(1): 105 - 119

D. M. Arduino, A. R. Esteves, C. R. Oliveira and S. M. Cardoso


DOI: 10.2174/187152710790966687




Raf Inhibitors as Therapeutic Agents Against Neurodegenerative Diseases

, 9(1): 120 - 127

Sarah Burgess and Valentina Echeverria


DOI: 10.2174/187152710790966632




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science